NCT06305156

Brief Summary

Bone mineral density is an important measurement to detect osteoporosis. The goal of this clinical trial is to compare bone mineral density measurements in CT examinations and DXA scans. The main question it aims to answer is:

  • How good is the measurement of bone mineral density in the new photon-counting CT in comparison to DXA
  • How can we optimize the CT scan for bone mineral density Participants will undergo:
  • Clinically indicated CT scan on day of inclusion
  • Study related DXA scan on a separate appointment

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
167

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 22, 2024

Completed
19 days until next milestone

First Posted

Study publicly available on registry

March 12, 2024

Completed
1 day until next milestone

Study Start

First participant enrolled

March 13, 2024

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 19, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 19, 2025

Completed
Last Updated

January 13, 2026

Status Verified

January 1, 2026

Enrollment Period

1.8 years

First QC Date

February 22, 2024

Last Update Submit

January 10, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Bone mineral density CT

    Bone mineral density derived from CT Scan

    Immediately after CT scan of the participant.

  • Bone mineral density Dual-energy x-ray absorptiometry (DXA)

    Bone mineral density derived from DXA Scan

    Immediately after DXA scan of the participant.

Secondary Outcomes (5)

  • Correlation between age and bone mineral density

    1 year

  • Correlation between sex and bone mineral density

    1 year

  • Correlation between height and bone mineral density

    1 year

  • Correlation between weight and bone mineral density

    1 year

  • Correlation between body mass index (BMI) and bone mineral density

    1 year

Study Arms (1)

Bone mineral density CT vs DXA

OTHER

Single arm study, all participants receive CT and DXA.

Diagnostic Test: Bone Mineral Density quantification

Interventions

In the first visit, participants receive clinically indicated CT scan, where bone mineral density will be derived. In a second, study related visit, participants will receive a DXA scan for bone mineral quantifications.

Bone mineral density CT vs DXA

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Informed Consent signed by the subject
  • Referral to a regular clinically indicated CT examination covering the lumbar area (e.g., Abdomen, Thorax + Abdomen, Neck + Thorax +Abdomen)
  • Informed written and oral consent (interpreter present in case of foreign language patients)
  • No contraindication to the clinically indicated CT examination

You may not qualify if:

  • Patients \< 18 years
  • Pregnant women
  • Vulnerable subjects
  • Contraindications to the clinically indicated CT scan
  • Multiple Myeloma
  • Diffuse bone metastasis
  • Fixateur interne in the lumbar spine
  • Kyphoplasty in the lumbar spine
  • Enterally administrated contrast agent
  • Obtaining informed consent is not possible
  • Withdrawal of consent orally or in writing
  • Inability to follow the procedures of the investigation, e.g., due to language problems, psychological disorders, dementia, etc. of the subject
  • Immobility (patients confined to a wheelchair or to bed)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Diagnostic and Interventional Radiology, University Hospital Zurich

Zurich, Canton of Zurich, 8091, Switzerland

Location

MeSH Terms

Conditions

OsteoporosisBone Diseases, Metabolic

Condition Hierarchy (Ancestors)

Bone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Hatem Alkadhi, MD, MPH

    Diagnostic and Interventional Radiology, University Hospital Zurich

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Senior Attending Physician, Vice Director of the Institute, Institute for Diagnostic and Interventional Radiology

Study Record Dates

First Submitted

February 22, 2024

First Posted

March 12, 2024

Study Start

March 13, 2024

Primary Completion

December 19, 2025

Study Completion

December 19, 2025

Last Updated

January 13, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations